Arsani William, Director at Design Therapeutics, Inc. (DSGN), bought 2,235,000 shares at $2.15 ($5.4M) on 2023-08-28, disclosed to the SEC on 2023-08-30.
Open-market purchase of $5.4M DSGN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.15 | 275,000 | $591K | 11.0% |
| 2 | $2.44 | 1,960,000 | $4.8M | 89.0% |
| Total | $2.40 avg | 2,235,000 | $5.4M | 100% |
| Filing → |
| DSGN | BUY | 2022-03-22 | $950K | — | Filing → |
| DSGN | BUY | 2021-09-02 | $618K | — | Filing → |
| DSGN | BUY | 2021-04-01 | $14.0M | — | Filing → |